Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-06-07
1997-07-01
Kishore, PhD, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
436829, A61K 9127
Patent
active
056435991
ABSTRACT:
An improved liposome and related methods for using the liposome to facilitate the delivery of an extracellular agent to the cytoplasm of a target cell are provided. The improved liposomes include a phagosomal membrane permeabilizer, such as a hemolysin.
REFERENCES:
patent: 4863874 (1989-09-01), Wassef et al.
patent: 4921757 (1990-05-01), Wheatley et al.
patent: 4925661 (1990-05-01), Huang
patent: 5225212 (1993-07-01), Martin et al.
Lee, K-D, et al., "Delivery of Macromolecules into Cytosol Using Liposomes Containing Hemolysin from Listeria monocytogenes", J. Biol. Chem. 271 (13): 7249-7252 (1996).
Torchilin, V.P., et al., "pH-Sensitive Liposomes", J. Liposome Research 3 (2): 201-255 (1993).
Yamanaka, Chem Abstracts, 107, #29591.
Glushakova, Chem Abstracts, 103, #208093.
Glushakova, Chem Abstract, 103, 194758.
Yamanaka, H., et al., "Preparation of specific antiserum against Vibrio vulnificus hemolysin by immunization with hemolysin-bound liposomes", FEMS Microbiology Ltrs. 41:313-316 (1987).
Bron, R., et al., "Cellular Cytoplasmic Delivery of Polypeptide Toxin by Reconstituted Influenza Virus Envelopes (Virosomes)", Biochem, 33:9110-9117 (1994).
Bakker-Woudenberg, I. et al., Effect of Lipid Composition on Activity of Liposome-Entrapped Ampicillin against Intracelluar Listeria monocytogenes, Antimicrobial Agents and Chem., Oct. 1988, 1560-1564.
Choi, M. et al., pH-sensitive Liposomes Containing Polymerized Phosphatidylethanolamine and Fatty Acid, J. Biochem, 112, 694-699 (1992).
Chu, C. et al., Efficiency of Cytoplasmic Delivery by pH-sensitive Liposomes to Cells in Culture, Pharmaceutical Research, vol. 7, No. 8, 1990, 824-834.
Collins, D. et al., Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols, Biochimica et Biophysica Acta. 1025 (1990) 234-242 Elsevier.
Collins, D., Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J. of Immunology, vol. 148, No. 11, 3336-3341, Jun. 1, 1992.
Connor. J. et al., pH-sensitive liposomes: Acid-induced liposome fusion, Proc. Natl. Acad. Sci. USA, vol. 81, 1715-1718, Mar. 1984.
Desiderio, J. and S.G. Campbell, Liposome-Encapsulated Cephalothin in the Treatment of Experimental Murine Salmonellosis, RES: J of Reticuloendothelial Soc. 34:279-287 (1983).
Desiderio, J. and S.G. Campbell, Immunization against experimental murine salmonellosis with liposome-associated O-antigen, Infection and Immunity, vol. 48, No. 3, Jun. 1985, pp. 658-663.
Duzgunes, N. et al., Proton-induced fusion of oleic acid-phophatidylethanolamine liposome, Biochemistry 24:3091-3098, 1985.
Fattal, E. et al., Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis, Antimicrobial Agents and Chemotherapy, vol. 35, No. 4, Apr. 1991, pp. 770-772.
Fidler, I. et al., Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages Cancer Research 40:4460-4466 Dec. 1980.
Goren, M. et al., Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of mycobacterium tuberculosis, Proc Natl. Acad. Sci USA, vol. 73, No. 7, Jul. 1976, pp. 2510-2514.
Harding, C. et al., Liposome-encapsulated antigens engender lysosomal processing for class II MCH presentation and cytosolic processing for class I presentation, J. of Immunology, 147:2860-63 (1991).
Harding, C. et al., Lipsome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells, Cell 64:393-401, Jan. 25, 1991.
Hart. P.D'arcy and M. Young, The effect of inhibitors and enhancers of phagosome-lysosome fusion in cultured macrophages on the phagosome membrances of ingested yeasts, Exp. Cell Res. 118 (1979) 365-375.
Harwood, J., Understanding liposomal properties to aid their clinical usage, TIBS 17, Jun. 1992, 203-204.
Hazemoto, N. et al., pH-sensitive liposomes composed of phosphatidylethanolamine and fatty acid, Chem. Pharm. Bull. 38(3) 748-751 (1990).
Nair, S. et al., Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytoxic T lymphocyte response in vitro, J. Exp. Med., 175:609-612, Feb. 1992.
Paphadjopoulos, D., et al., Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy, Proc. Natl Acad. Sci. USA 88:11460-11464, Dec. 1991.
Reddy, R. et al., pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein, J. of Immunol. Methods 141:157-163 (1991).
Straubinger, R., [28] pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells, Methods of Enzymology 221:361-376 (1993).
Straubinger, R. et al., Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles, Cell 32:1069-1079, 1983.
Tadakuma, T. et al., Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes, Antimicrobial Agents and Chemotherapy, vol. 28, No. 1, Jul. 1985, pp. 28-32.
Lee Kyung-Dall
Portnoy Daniel A.
Swanson Joel A.
Kishore, PhD Gollamudi S.
President and Fellows of Harvard College
University of Pennsylvania
LandOfFree
Intracellular delivery of macromolecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular delivery of macromolecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular delivery of macromolecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-594957